RE:In normal market reaction the SP should have gone upThey alienated and abandoned the investors who would have driven the price up today. The earnings report was actually really good. The share price is a reflection of the leadership team's past decisions. I do appreciate the turnaround in profitability, which should be enough to drive share price appreciation. Clearly there wasn't huge success in the patients that completed the TH-1902 trial. I'm guessing they'll have some parts and pieces that look good and have potential in combination therapy, but no standout results on their own. If there was, I think we would have heard about that today. I am pleased to hear them say there were no DLT's. That's a positive improvement.